Sight Sciences, Inc.: H.C. Wainwright initiates coverage with buy rating and $14 target price
SGHT•H.C. Wainwright initiated coverage of Sight Sciences with a buy rating and a $14 price target.
Related News
PNC's Q3 revenue grows slightly less than expected on tepid capital markets activity
PNC•
IonQ, Inc.: Rosenblatt Securities cuts target price to $70 from $100
IONQ•
Granite Construction publishes update to financial calendar
GVA•
Core Scientific updates financial calendar
CORZ•
Immunocore doses first patient in Phase 1 trial of IMC-S118AI for type 1 diabetes
IMCR•